Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


19.07.2021

1 Biochemistry (Mosc)
1 BMJ
4 Brain
3 J Alzheimers Dis
1 J Biol Chem
2 J Neurochem
3 JAMA Intern Med
1 Nat Rev Neurol
2 Nature
6 Neurology
1 Neurosci Lett


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Biochemistry (Mosc)

  1. KHASPEKOV LG
    Current Views on the Role of Stress in the Pathogenesis of Chronic Neurodegenerative Diseases.
    Biochemistry (Mosc). 2021;86:737-745.
    PubMed         Abstract available


    BMJ

  2. DYER O
    FDA calls for investigation into industry influence during Alzheimer's drug approval.
    BMJ. 2021;374:n1778.
    PubMed        


    Brain

  3. GOURMAUD S, Stewart DA, Irwin DJ, Roberts N, et al
    The role of mTORC1 activation in seizure-induced exacerbation of Alzheimer's disease.
    Brain. 2021 Jul 15. pii: 6321945. doi: 10.1093.
    PubMed         Abstract available

  4. BERRON D, van Westen D, Ossenkoppele R, Strandberg O, et al
    Corrigendum to: Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321152. doi: 10.1093.
    PubMed        

  5. PEREIRA JB, Janelidze S, Smith R, Mattsson-Carlgren N, et al
    Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321226. doi: 10.1093.
    PubMed         Abstract available

  6. BAILES SM, Lewis LD
    Distinct cardiac-locked brain pulsations in Alzheimer's disease.
    Brain. 2021 Jul 9. pii: 6318392. doi: 10.1093.
    PubMed        


    J Alzheimers Dis

  7. DE LA TORRE JC, Gonzalez-Lima F
    The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions1.
    J Alzheimers Dis. 2021 Jul 9. pii: JAD210736. doi: 10.3233/JAD-210736.
    PubMed        

  8. CHEN S, Song Y, Xu W, Hu G, et al
    Impaired Memory Awareness and Loss Integration in Self-Referential Network Across the Progression of Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Jul 9. pii: JAD210541. doi: 10.3233/JAD-210541.
    PubMed         Abstract available

  9. SIBLE IJ, Bangen KJ, Blanken AE, Ho JK, et al
    Antemortem Visit-To-Visit Blood Pressure Variability Predicts Cerebrovascular Lesion Burden in Autopsy-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 7. pii: JAD210435. doi: 10.3233/JAD-210435.
    PubMed         Abstract available


    J Biol Chem

  10. VALVERDE A, Dunys J, Lorivel T, Debayle D, et al
    Dipeptidyl peptidase 4 contributes to Alzheimer's disease-like defects in a mouse model and is increased in sporadic Alzheimer's disease brains.
    J Biol Chem. 2021 Jul 12:100963. doi: 10.1016/j.jbc.2021.100963.
    PubMed         Abstract available


    J Neurochem

  11. KORECKA M, Shaw LM
    Mass spectrometry-based methods for robust measurement of Alzheimer's Disease biomarkers in biological fluids.
    J Neurochem. 2021 Jul 10. doi: 10.1111/jnc.15465.
    PubMed         Abstract available

  12. MICHNO W, Blennow K, Zetterberg H, Brinkmalm G, et al
    Refining the amyloid beta peptide and oligomer fingerprint ambiguities in Alzheimer's disease: mass spectrometric molecular characterization in brain, CSF, blood and plasma.
    J Neurochem. 2021 Jul 10. doi: 10.1111/jnc.15466.
    PubMed         Abstract available


    JAMA Intern Med

  13. STEINBROOK R
    The Accelerated Approval of Aducanumab for Treatment of Patients With Alzheimer Disease.
    JAMA Intern Med. 2021 Jul 13. pii: 2782122. doi: 10.1001/jamainternmed.2021.4622
    PubMed        

  14. DUNN B, Stein P, Cavazzoni P
    Approval of Aducanumab for Alzheimer Disease-the FDA's Perspective.
    JAMA Intern Med. 2021 Jul 13. pii: 2782119. doi: 10.1001/jamainternmed.2021.4607
    PubMed        

  15. MITCHELL SL, D'Agata EMC, Hanson LC, Loizeau AJ, et al
    The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial.
    JAMA Intern Med. 2021 Jul 12. pii: 2782003. doi: 10.1001/jamainternmed.2021.3098
    PubMed         Abstract available


    Nat Rev Neurol

  16. KARLAWISH J, Grill JD
    The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDA.
    Nat Rev Neurol. 2021 Jul 15. pii: 10.1038/s41582-021-00540.
    PubMed        


    Nature

  17. BARRON JJ, Molofsky AV
    A protective signal between the brain's supporting cells in Alzheimer's disease.
    Nature. 2021 Jul 14. pii: 10.1038/d41586-021-01870.
    PubMed        

  18. MCALPINE CS, Park J, Griciuc A, Kim E, et al
    Astrocytic interleukin-3 programs microglia and limits Alzheimer's disease.
    Nature. 2021 Jul 14. pii: 10.1038/s41586-021-03734.
    PubMed         Abstract available


    Neurology

  19. ROBERTS G, Durcan Mrcpi R, Donaghy PC, Lawley S, et al
    Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.
    Neurology. 2021 Apr 21. pii: WNL.0000000000012060.
    PubMed         Abstract available

  20. TAO Q, Alvin Ang TF, Akhter-Khan SC, Itchapurapu IS, et al
    Impact of C-Reactive Protein on Cognition and Alzheimer Disease Biomarkers in Homozygous Apolipoprotein E varepsilon4 Carriers.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012512.
    PubMed         Abstract available

  21. BOCANCEA DI, Catharina van Loenhoud A, Groot C, Barkhof F, et al
    Measuring Resilience and Resistance in Aging and Alzheimer Disease Using Residual Methods: A Systematic Review and Meta-analysis.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012499.
    PubMed         Abstract available

  22. GROTHE MJ, Moscoso A, Ashton NJ, Karikari TK, et al
    Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012513.
    PubMed         Abstract available

  23. POGGESI A
    Resilience and Resistance in Aging and Alzheimer Disease: Another Step to Fill the Gap Between Clinicians and Researchers.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012500.
    PubMed        

  24. WILSON RS, Wang T, Yu L, Grodstein F, et al
    Cognitive Activity and Onset Age of Incident Alzheimer Disease Dementia.
    Neurology. 2021 Jul 14. pii: WNL.0000000000012388.
    PubMed         Abstract available


    Neurosci Lett

  25. WANDER CM, Song J
    The Neurogenic Niche in Alzheimer's disease.
    Neurosci Lett. 2021 Jul 13:136109. doi: 10.1016/j.neulet.2021.136109.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: